Merck & Co. Inc. diskutieren
Merck & Co. Inc.
WKN: A0YD8Q / Symbol: MRK / Name: Merck & Co / Aktie / Pharmazeutika / Large Cap /
100,00 €
-0,20 %
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at UBS Group AG from $148.00 to $142.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Bank of America Co. from $150.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its price target lowered by analysts at Barclays PLC from $145.00 to $142.00. They now have an "overweight" rating on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Merck & Co., Inc. (NYSE: MRK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $155.00 price target on the stock.
Ratings data for MRK provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in MarketAxess Holdings diskutieren